Showing results (641-650 of 736) with videos related to

Sort By:
Pageof 74
British Journal of Haematology|August 31, 2019
Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomesJithma P Abeykoon, Saurabh Zanwar, Stephen M Ansell, et al.
American Journal of Hematology|March 10, 2025
Depth of Response From Fixed-Duration Treatment Is Associated With Superior Survival in Waldenstrom MacroglobulinemiaJonas Paludo, Jithma P Abeykoon, Nirosha D Perera, et al.
Hematological Oncology|November 29, 2024
Molecular Features of Diffuse Large B-Cell Lymphoma Associated With Primary Treatment ResistanceAllison M Bock, Kerstin Wenzl, Joseph P Novak, et al.
Hematological Oncology|May 31, 2023
Molecular classification and identification of an aggressive signature in low-grade B-cell lymphomasMelissa A Hopper, Kerstin Wenzl, Keenan T Hartert, et al.
Leukemia & Lymphoma|September 24, 2020
Analysis and impact of a multidisciplinary lymphoma virtual tumor boardThomas M Habermann, Arushi Khurana, Ruth Lentz, et al.
Leukemia|November 30, 2019
IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological featuresSurbhi Sidana, Daniel P Larson, Patricia T Greipp, et al.
Cell Reports. Medicine|August 28, 2025
Tumor evolution and immune microenvironment dynamics in primary and relapsed mantle cell lymphomaHui Wan, Weicheng Ren, Mingyu Yang, et al.
Leukemia|November 5, 2004
A phase I study of 153Sm-EDTMP with fixed high-dose melphalan as a peripheral blood stem cell conditioning regimen in patients with multiple myelomaA Dispenzieri, G A Wiseman, M Q Lacy, et al.
International Journal of Radiation Oncology, Biology, Physics|December 23, 2022
Don't Put the CART Before the Horse: The Role of Radiation Therapy in Peri-CAR T-cell Therapy for Aggressive B-cell Non-Hodgkin LymphomaOmran Saifi, William G Breen, Scott C Lester, et al.
Haematologica|June 15, 2023
Consolidative radiotherapy for residual fluorodeoxyglucose activity on day +30 post CAR T-cell therapy in non-Hodgkin lymphomaOmran Saifi, William G Breen, Scott C Lester, et al.
Pageof 74